Managing Pain without Addiction

The Bio Report - A podcast by Levine Media Group - Wednesdays

Categories:

Ketan Mehta, founder and CEO of Tris Pharma, discusses its experimental opiod Cebranopadol, how it modulates the addictive potential by targeting two receptors at once, and its potential to address the opioid crisis.